Overexpression of endophilin A1 exacerbates synaptic alterations in a mouse model of Alzheimer’s disease

Qing Yu, Yongfu Wang, Shijun Yan, Nicola Origlia, Grazia Rutigliano, Haiyang Yu, James Alexander Ainge, Shi Fang Yan, Frank Gunn-Moore, Shirley ShiDu Yan

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

Endophilin A1 (EP) is a protein enriched in synaptic terminals that has been linked to Alzheimer’s disease (AD). Previous in vitro studies have shown that EP can bind to a variety of proteins, which elicit changes in synaptic transmission of neurotransmitters and spine formation. Additionally, we previously showed that EP protein levels are elevated in AD patients and AD transgenic animal models. Here, we establish the in vivo consequences of upregulation of EP expression in amyloid-β peptide (Aβ)-rich environments, leading to changes in both long-term potentiation and learning and memory of transgenic animals. Specifically, increasing EP augmented cerebral Aβ accumulation. EP-mediated signal transduction via reactive oxygen species (ROS)/p38 mitogen-activated protein (MAP) kinase contributes to Aβ-induced mitochondrial dysfunction, synaptic injury, and cognitive decline, which could be rescued by blocking either ROS or p38 MAP kinase activity.
Original languageEnglish
Article number2968
Number of pages14
JournalNature Communications
Volume9
DOIs
Publication statusPublished - 30 Jul 2018

Fingerprint

Dive into the research topics of 'Overexpression of endophilin A1 exacerbates synaptic alterations in a mouse model of Alzheimer’s disease'. Together they form a unique fingerprint.

Cite this